Migration rate using fully covered metal stent in anastomotic strictures after liver transplantation: Results from the BASALT study group.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Conigliaro Rita, Pigò Flavia, Bertani Helga, BASALT Group:, Greco Salvatore, Burti Cesare, Indriolo Amedeo, Di Sario Antonio, Ortolani Alessio, Maroni Luca, Tringali Andrea, Barbaro Federico, Costamagna Guido, Magarotto Andrea, Masci Enzo, Mutignani Massimiliano, Forti Edoardo, Tringali Alberto, Parodi Maria C, Assandri Lorenzo, Marrone Ciro, Fantin Alberto, Penagini Roberto, Cantù Paolo, Liver Transplant Centers:, Di Benedetto Fabrizio, Ravelli Paolo, Vivarelli Marco, Agnes Salvatore, Mazzaferro Vincenzo, De Carlis Luciano, Andorno Enzo, Cillo Umberto, Rossi Giorgio
Аннотация
PATIENTS AND METHODS: Ninety-one patients (mean age 55.9 ± 7.6 SD; 73 males) from nine Italian transplantation centres, had a cSEMS positioned for post-OLT-AS between 2007 and 2017. Forty-nine (54%) patients were treated with cSEMS as a second-line treatment.
RESULTS: All the procedures were successfully performed without immediate complications. After ERCP, adverse events occurred in 11% of cases (2 moderate pancreatitis and 8 cholangitis). In 49 patients (54%), cSEMSs migrated. After cSEMS removal, 46 patients (51%) needed further endoscopic (45 patients) or radiological (1 patient) treatments to solve the AS. Lastly, seven patients underwent surgery. Multivariable stepwise logistic regression showed that cSEMS migration was the only factor associated with further treatments (OR 2.6, 95% CI 1.0-6.6; p value 0.03); cSEMS implantation before 12 months from OLT was associated with stent migration (OR 5.2, 95% CI 1.7-16.0; p value 0.004).
CONCLUSIONS: cSEMS appears to be a safe tool to treat AS. cSEMS migration is the main limitation to its routinary implantation and needs to be prevented, probably with the use of new generation anti-migration stents.